Bill Snyder

January 25, 2018

Directorships honor VUMC’s critical missions

Vanderbilt University Medical Center (VUMC) on Monday held its first Directorship Celebration to honor and support eight of its leaders in clinical care, research, education and administration.

By Bill Snyder
Insulin in vials
January 25, 2018

Study may point to new ways to reverse insulin resistance

Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.

By Bill Snyder
January 18, 2018

Investigators eye new target for treating movement disorders

Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson’s disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.

By Bill Snyder
January 16, 2018

VUMC researchers find a way to ‘starve’ cancer

Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine.

By Bill Snyder
January 12, 2018

BOLD view of white matter

Vanderbilt investigators have discovered that functional MRI detects neural activity in both gray and white matter in the brain, suggesting new ways to investigate diseases such as Alzheimer’s and multiple sclerosis.

By Bill Snyder
January 11, 2018

VUMC joins national effort to block global pandemics of potentially lethal viruses

The U.S. Defense Advanced Research Projects Agency (DARPA) has signed a five-year cooperative agreement worth up to $28 million with Vanderbilt University Medical Center (VUMC) to develop methods for preventing the global spread of viruses like chikungunya and Zika.

By Bill Snyder
January 8, 2018

Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.
By Bill Snyder
January 4, 2018

Research sheds light on how microtubules are assembled

Microtubules are the “railroad tracks” essential for moving intracellular “freight” around in the cell. They’re also part of the spindle that pulls the two centrosomes apart during cell division.
By Bill Snyder
December 15, 2017

The toll of dysphagia

Impaired swallowing — dysphagia — affects 3 percent of hospital inpatients, who have longer hospital stays and are more likely to require post-acute care services.
By Bill Snyder
December 14, 2017

Crowe elected a fellow of the National Academy of Inventors

James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center (VUMC), has been named a fellow of the National Academy of Inventors (NAI).
By Bill Snyder
December 14, 2017

Matrix biology society honors Hudson’s contributions

Vanderbilt University Medical Center (VUMC) biochemist Billy Hudson, PhD, has been awarded the 2018 Distinguished Investigator Prize by the International Society for Matrix Biology for his contributions to the field of matrix biology.
By Bill Snyder
December 14, 2017

UCLA’s Lewis set for next Discovery Lecture

Roger Lewis, MD, PhD, a national expert on methods that can improve the flexibility and efficiency of clinical trials, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 4, 2018.
By Bill Snyder
1 … 55 56 57 58 59 … 110